Home | Welcome to Contract Pharma   
Last Updated Sunday, July 27 2014
Print

Search Results for 'Financial Report: AMRI'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 6, 2014
Decline in royalties impacts results Read More »
Published April 16, 2014
Will transition DDS ops to other sites Read More »
Published April 3, 2014
AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s… Read More »
By Kristin Brooks
Published March 3, 2014
Revenues down 12% in the quarter Read More »
By Kristin Brooks
Published February 12, 2014
Achieves record contract revenues Read More »
Published November 6, 2013
Contract revenue up 16% in the quarter Read More »
Published August 6, 2013
Revenues up 19% in the quarter Read More »
Published November 6, 2012
Large-scale manufacturing revenue up 14% Read More »
Published November 7, 2008
AMRI 3Q Revenues: $61.4 million (+29%) 3Q Earnings: $7.0 million (+250%) YTD Revenues: $172.9 million (+19%) YTD Earnings: $17.4 million (+78%) Comments: Total contract revenue for the quarter was $54.1 million (+30%). Discovery Servi… Read More »
Published February 27, 2012
See current Good Manufacturing Practice.… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On